References
- Waters WE. Headache. Littleton, MA: PSG/Wright Publishing, 1986: 37–9 (Series on clinical epidemiology, vol 2)
- Hopkins A, Ziegler D. Headache—the size of the problem. In: Hopkins A, ed. Headache: problems in diagnosis and management. Philadelphia: WB Saunders, 1988: 1–7
- Fitzpatrick RM, Hopkins A. Illness behaviour and headache, and the sociology of consultations for headache. In: Hopkins, ed,2 pp 351–85
- Kalendovsky Z, Austin JH. Changes in blood clotting systems during migraine attacks. Headache 1977: 16(6): 293–312
- Merrett J, Peatfield RC, Rose FC, et al. Food related antibodies in headache patients. J Neurol Neurosurg Psychiatry 1983: 46(8): 738–42
- Kudrow L. Paradoxical effects of frequent analgesic use. Adv Neurol 1982: 33: 335–41
- Pradalier A, Clapin A, Dry J. Non-steroid anti-inflammatory drugs in the treatment and long-term prevention of migraine attacks. Headache 1988: 28(8): 550–7
- Diamond S. Treatment of migraine with isometheptene, acetaminophen, and dichloralphenazone combination: a double-blind, crossover trial. Headache 1976: 15(4): 282–7
- Edmeads J. Headache. In: Rakel R, ed. Conn's current therapy. Philadelphia: WB Saunders, 1986: 717–22
- Fanciullacci M, Granctal G, Sicuteri F. Ergotamine and methysergide as serotonin partial agonists in migraine. Headache 1976: 16(5): 226–31
- Perrin VL. Clinical pharmacokinetics of eigotamine in migraine and cluster headache. Clin Pharmacokinet 1985: 10(4): 334–52
- Rowsell AR, Neylan C, Wilkinson M. Ergotamine induced headaches in migrainous patients. Headache 1973: 13(2): 65–7
- Saper JR. Drug overuse among patients with headache. Neurol Clin 1983: 1(2): 465–77
- Couch JR Jr. Diamond S. Status migrainosus: causative and therapeutic aspects. Headache 1983: 23(3): 94–101
- Lane PL, Ross R. Intravenous chlorpromazine—preliminary results in acute migraine. Headache 1985: 25(6): 302–4
- Callaham M, Raskin N. A controlled study of dihydroergotamine in the treatment of acute migraine headache. Headache 1986: 26(4): 168–71
- Gallagher RM. Emergency treatment of intractable migraine. Headache 1986: 26(2): 74–5
- Johnston DL. Outpatient treatment of acute migraine. (Letter) Headache 1984: 24(5): 282
- Rosen JA. Observations on the efficacy of propranolol for the prophylaxis of migraine. Ann Neurol 1983: 13(1): 92–3
- Steiner TJ, Joseph R, Hedman C, et al. Metoprolol in the prophylaxis of migraine: parallel groups comparison with placebo and dose-ranging follow-up. Headache 1988: 28(1): 15–23
- Medina JL. Effectiveness of nadolol in a clinic population of migrainous patients. Headache 1988: 28(2): 99–102
- Couch JR. Hassanein RS. Amitriptyline in migraine prophylaxis. Arch Neurol 1979: 36(11): 695–9
- Meyer JS, Hardenberg J. Clinical effectiveness of calcium entry blockers in prophylactic treatment of migraine and cluster headaches. Headache 1983: 23(6): 266–77
- Solomon GD. Comparative efficacy of calcium antagonist drugs in the prophylaxis of migraine. Headache 1985: 25(7): 368–71
- Bussone G, Baldini S, D'Andrea G, et al. Nimodipine versus flunarizine in common migraine: a controlled pilot trial. Headache 1987: 27(2): 76–9